Raffaella Willmann studied Biology in Italy and obtained her PhD in Biochemistry in Konstanz (Germany). After a first post-doc position in muscle physiology in Konstanz, she joined the group of Prof. Fuhrer in at the University of Zürich in 2000. There, she worked on a project on the formation and stabilization of the neuromuscular junction. She joined TREAT-NMD on March 1st, 2007 as scientific writer and Activity coordinator. In this position she coordinated the creation of standard operating protocol for preclinical efficacy assays on mammalian models for muscular dystrophies and co-authored several papers on quality and robustness of preclinical data for potential therapies.
Since 2012, she is affiliated to the Swiss Foundation for Research on Muscle Diseases as scientific assistant.